|
GS185131: GO:0044699 single-organism process
|
|
GS174327: HP:0003198 Myopathy
|
|
GS210158: GO:0006084 acetyl-CoA metabolic process
|
|
GS174310: HP:0100705 Abnormality of the glial cells
|
|
GS128223: Proteins found to be modified by at least two drugs of abuse
|
|
GS189855: GO:0043168 anion binding
|
|
GS190997: GO:0044281 small molecule metabolic process
|
|
GS172294: HP:0001510 Growth delay
|
|
GS123959: Taurine interacting genes (MeSH:D013654) in CTD
|
|
GS208404: GO:0045333 cellular respiration
|
|
GS178388: GO:0055114 oxidation-reduction process
|
|
GS123265: Estradiol interacting genes (MeSH:D004958) in CTD
|
|
GS179795: GO:0019866 organelle inner membrane
|
|
GS176385: HP:0001249 Intellectual disability
|
|
GS201556: GO:0000104 succinate dehydrogenase activity
|
|
GS135648: cocaine induced activation 11 (Cocia11, Published QTL Chr 13)
|
|
GS34121: Cerebellum Gene expression correlates of Open Field locomotion (activity beam breaks) 45-60 min post 2nd cocaine in Males BXD
|
|
GS186213: GO:0022904 respiratory electron transport chain
|
|
GS196343: GO:0036094 small molecule binding
|
|
GS172054: HP:0001507 Growth abnormality
|
|
GS199767: GO:0006099 tricarboxylic acid cycle
|
|
GS177404: GO:0005737 cytoplasm
|
|
GS177265: GO:0048731 system development
|
|
GS201251: GO:0044424 intracellular part
|
|
GS172060: HP:0001508 Failure to thrive
|
|
GS188142: GO:0048856 anatomical structure development
|
|
GS135228: Angiostrongylus costaricensis nematode susceptibility 2 (Acsns2, Published QTL Chr 13)
|
|
GS176840: HP:0001911 Abnormality of granulocytes
|
|
GS182519: GO:0006732 coenzyme metabolic process
|
|
GS183543: GO:0051179 localization
|
|
GS193215: GO:0006084 acetyl-CoA metabolic process
|
|
GS172428: HP:0002151 Increased serum lactate
|
|
GS123943: Curcumin interacting genes (MeSH:D003474) in CTD
|
|
GS209108: GO:0000166 nucleotide binding
|
|
GS202555: GO:0043436 oxoacid metabolic process
|
|
GS175601: HP:0002086 Abnormality of the respiratory system
|
|
GS178284: GO:0031090 organelle membrane
|
|
GS176203: HP:0000478 Abnormality of the eye
|
|
GS202997: GO:0016635 oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor
|
|
GS127931: Olfactory bulb - Allen Mouse Brain Atlas
|
|
GS172854: HP:0004302 Functional motor problems.
|
|
GS197469: GO:0044455 mitochondrial membrane part
|
|
GS176591: HP:0001276 Hypertonia
|
|
GS181430: GO:0006637 acyl-CoA metabolic process
|
|
GS173697: HP:0001319 Neonatal hypotonia
|
|
GS202766: GO:0050660 flavin adenine dinucleotide binding
|
|
GS192299: GO:0006793 phosphorus metabolic process
|
|
GS198220: GO:0006637 acyl-CoA metabolic process
|
|
GS175390: HP:0011007 Age of onset
|
|
GS196808: GO:0032501 multicellular organismal process
|
|
GS171708: HP:0000359 Abnormality of the inner ear
|
|
GS182173: GO:0031967 organelle envelope
|
|
GS186744: GO:0043226 organelle
|
|
GS182835: GO:0005622 intracellular
|
|
GS193942: GO:0035383 thioester metabolic process
|
|
GS127934: Retrohippocampal region - Allen Mouse Brain Atlas
|
|
GS194111: GO:0097159 organic cyclic compound binding
|
|
GS35096: Cerebellum Gene expression correlates of Open Field TOTAL locomotion (activity beam breaks) in Males BXD
|
|
GS34176: Cerebellum Gene expression correlates of Open Field rears 45-60 min post 2nd cocaine in Males BXD
|
|
GS175544: HP:0008972 Decreased activity of mitochondrial respiratory chain
|
|
GS206742: GO:0043167 ion binding
|
|
GS177695: GO:0051187 cofactor catabolic process
|
|
GS209010: GO:1901575 organic substance catabolic process
|
|
GS175528: HP:0000007 Autosomal recessive inheritance
|
|
GS176914: HP:0002171 Gliosis
|
|
GS171815: HP:0001574 Abnormality of the integument
|
|
GS181473: GO:0005488 binding
|
|
GS175526: HP:0000005 Mode of inheritance
|
|
GS175823: HP:0002093 Respiratory insufficiency
|
|
GS180036: GO:0032501 multicellular organismal process
|
|
GS192512: GO:0003824 catalytic activity
|
|
GS207616: GO:0016020 membrane
|
|
GS198004: GO:0007399 nervous system development
|
|
GS173243: HP:0001336 Myoclonus
|
|
GS198971: GO:0031966 mitochondrial membrane
|
|
GS197244: GO:0044237 cellular metabolic process
|
|
GS199560: GO:0043648 dicarboxylic acid metabolic process
|
|
GS198755: GO:0016491 oxidoreductase activity
|
|
GS173535: HP:0001874 Abnormality of neutrophils
|
|
GS198058: GO:0005743 mitochondrial inner membrane
|
|
GS175529: HP:0000001 All
|
|
GS194138: GO:0005739 mitochondrion
|
|
GS175527: HP:0000006 Autosomal dominant inheritance
|
|
GS127938: Striatum - Allen Mouse Brain Atlas
|
|
GS206737: GO:0043168 anion binding
|
|
GS173872: HP:0011368 Epidermal thickening
|
|
GS186740: GO:0043229 intracellular organelle
|
|
GS136248: molar crown diameter QTL 1 (Mcdq1, Published QTL Chr 13)
|
|
GS204477: GO:0045281 succinate dehydrogenase complex
|
|
GS208012: GO:0044464 cell part
|
|
GS87380: Table S1: Additional data file 1 is a table listing the results of two-way ANOVA (FDR < 1%). (Whole Table) [DRG]
|
|
GS201252: GO:0044425 membrane part
|
|
GS865: Sey_Pax6_Age_Reduced_Linear_Incr
|
|
GS170980: HP:0011362 Abnormal hair quantity
|
|
GS201250: GO:0044429 mitochondrial part
|
|
GS135668: circadian period of locomotor activity 11 (Cplaq11, Published QTL Chr 13)
|
|
GS174385: HP:0002088 Abnormality of the lung
|
|
GS174071: HP:0009125 Lipodystrophy
|
|
GS193220: GO:0006082 organic acid metabolic process
|
|
GS34295: Cerebellum Gene expression correlates of Activity in 30 second interval post 3rd tone shock pairing in Males BXD
|
|
GS182966: GO:0006099 tricarboxylic acid cycle
|
|
GS209846: GO:0046356 acetyl-CoA catabolic process
|
|
GS127928: Lateral septal complex - Allen Mouse Brain Atlas
|
|
GS197016: GO:0032991 macromolecular complex
|
|
GS199635: GO:0005622 intracellular
|
|
GS171461: HP:0011121 Abnormality of skin morphology
|
|
GS127935: Striatum dorsal region - Allen Mouse Brain Atlas
|
|
GS208795: GO:0015980 energy derivation by oxidation of organic compounds
|
|
GS173722: HP:0002490 Increased CSF lactate
|
|
GS213076: Genes with suggestive difference in (B6) vs (B6PF1 + PB6F1 + PWD) comparison
|
|
GS121437: Fluorouracil interacting genes (MeSH:D005472) in CTD
|
|
GS185926: GO:0050662 coenzyme binding
|
|
GS87381: Table S1: Additional data file 1 is a table listing the results of two-way ANOVA (FDR < 1%). (Whole Table) [DRG]
provisional
|
|
GS196941: GO:0008150 biological_process
|
|
GS172180: HP:0012103 Abnormality of the mitochondrion
|
|
GS124695: arsenic trioxide interacting genes (MeSH:C006632) in CTD
|
|
GS175539: HP:0007256 Abnormality of pyramidal motor function
|
|
GS201256: GO:0044422 organelle part
|
|
GS86497: Table S2: Additional data file 2 - Lists of probe sets of genes with expression altered by acute and chronic morphine (ANOVA; FDR < 1%). C57BL/6J [DRG]
provisional
|
|
GS201431: GO:0005515 protein binding
|
|
GS173147: HP:0011283 Abnormality of the metencephalon
|
|
GS174070: HP:0009124 Abnormality of adipose tissue
|
|
GS187160: GO:0044707 single-multicellular organism process
|
|
GS202498: GO:0009109 coenzyme catabolic process
|
|
GS174305: HP:0000712 Emotional lability
|
|
GS35202: Cerebellum Gene expression correlates of Open Field - Total horizontal distance (cm) 0-15 min post saline in Males BXD
|
|
GS175016: HP:0001626 Abnormality of the cardiovascular system
|
|
GS190682: GO:0007275 multicellular organismal development
|
|
GS170825: HP:0002167 Neurological speech impairment
|
|
GS199267: GO:0043234 protein complex
|
|
GS193059: GO:0044446 intracellular organelle part
|
|
GS176172: HP:0001251 Ataxia
|
|
GS209564: GO:0043231 intracellular membrane-bounded organelle
|
|
GS185666: GO:0009109 coenzyme catabolic process
|
|
GS171274: HP:0100543 Cognitive impairment
|
|
GS171848: HP:0000598 Abnormality of the ear
|
|
GS204326: GO:0019752 carboxylic acid metabolic process
|
|
GS172516: HP:0001347 Hyperreflexia
|
|
GS175015: HP:0001627 Abnormality of the heart
|
|
GS204021: GO:0044707 single-multicellular organism process
|
|
GS170815: HP:0011400 Abnormal CNS myelination
|
|
GS175595: HP:0011017 Abnormality of cell physiology
|
|
GS126906: sodium arsenate interacting genes (MeSH:C009277) in CTD
|
|
GS171621: HP:0100851 Abnormal emotion/affect behavior
|
|
GS135980: wound healing/regeneration 7 (Heal7, Published QTL Chr 13)
|
|
GS135427: bone mechanical trait 6 (Bmch6, Published QTL Chr 13)
|
|
GS121369: Clofibric Acid interacting genes (MeSH:D002995) in CTD
|
|
GS185366: GO:0044248 cellular catabolic process
|
|
GS187277: GO:0009060 aerobic respiration
|
|
GS172030: HP:0000365 Hearing impairment
|
|
GS173028: HP:0004360 Abnormality of acid-base homeostasis
|
|
GS136222: mandible length 14 (Manln14, Published QTL Chr 13)
|
|
GS196806: GO:0032502 developmental process
|
|
GS135529: castaneus 10 week body weight 4 (C10bw4, Published QTL Chr 13)
|
|
GS135512: body weight day 30 males 2 (Bwem2, Published QTL Chr 13)
|
|
GS202364: GO:0048037 cofactor binding
|
|
GS127927: Hypothalamus - Allen Mouse Brain Atlas
|
|
GS181215: GO:0007399 nervous system development
|
|
GS203594: GO:0043226 organelle
|
|
GS172667: HP:0011805 Abnormality of muscle morphology
|
|
GS184750: GO:0000104 succinate dehydrogenase activity
|
|
GS177696: GO:0051186 cofactor metabolic process
|
|
GS210002: GO:0044444 cytoplasmic part
|
|
GS194909: GO:0006105 succinate metabolic process
|
|
GS198078: GO:0005749 mitochondrial respiratory chain complex II
|
|
GS175530: HP:0000002 Abnormality of body height
|
|
GS135401: body growth late QTL 10 (Bglq10, Published QTL Chr 13)
|
|
GS202764: GO:0050662 coenzyme binding
|
|
GS174331: HP:0002715 Abnormality of the immune system
|
|
GS172372: HP:0000648 Optic atrophy
|
|
GS192174: GO:0000166 nucleotide binding
|
|
GS203593: GO:0043227 membrane-bounded organelle
|
|
GS136721: susceptibility to lung cancer 23 (Sluc23, Published QTL Chr 13)
|
|
GS176898: HP:0002352 Leukoencephalopathy
|
|
GS210000: GO:0044446 intracellular organelle part
|
|
GS127924: Cerebral cortex - Allen Mouse Brain Atlas
|
|
GS127925: Hippocampal formation - Allen Mouse Brain Atlas
|
|
GS174131: HP:0002011 Abnormality of the central nervous system
|
|
GS194087: GO:0003674 molecular_function
|
|
GS121343: Flavonoids interacting genes (MeSH:D005419) in CTD
|
|
GS177356: GO:0003674 molecular_function
|
|
GS203590: GO:0043229 intracellular organelle
|
|
GS176245: HP:0011443 Abnormality of coordination
|
|
GS177309: GO:1901363 heterocyclic compound binding
|
|
GS176610: HP:0003593 Infantile onset
|
|
GS175119: HP:0001881 Abnormality of leukocytes
|
|
GS171201: HP:0001941 Acidosis
|
|
GS181270: GO:0005743 mitochondrial inner membrane
|
|
GS176345: HP:0003128 Lactic acidosis
|
|
GS174813: HP:0001638 Cardiomyopathy
|
|
GS180166: GO:0008152 metabolic process
|
|
GS192900: GO:0046356 acetyl-CoA catabolic process
|
|
GS176806: HP:0003812 Phenotypic variability
|
|
GS87137: Table S2: List of probe-sets of genes differentially expressed among the four inbred strains of mice. Gene Ranks [DRG]
provisional
|
|
GS171832: HP:0000118 Phenotypic abnormality
|
|
GS203886: GO:1901265 nucleoside phosphate binding
|
|
GS83966: cocaine induced activation 11 (Cocia11, Published QTL, Chr 13, MGI:3040202)
|
|
GS177382: GO:0097159 organic cyclic compound binding
|
|
GS171251: HP:0003549 Abnormality of connective tissue
|
|
GS177317: GO:0016627 oxidoreductase activity, acting on the CH-CH group of donors
|
|
GS127937: Striatum-like amygdalar nuclei - Allen Mouse Brain Atlas
|
|
GS192509: GO:0006810 transport
|
|
GS175167: HP:0011922 Abnormal activity of mitochondrial respiratory chain
|
|
GS172040: HP:0000962 Hyperkeratosis
|
|
GS127936: Striatum ventral region - Allen Mouse Brain Atlas
|
|
GS172989: HP:0001324 Muscle weakness
|
|
GS34454: Cerebellum Gene expression correlates of Novel environment locomotion (activity beam breaks) 15-30 min in the periphery in Females BXD
|
|
GS174505: HP:0000708 Behavioural/Psychiatric Abnormality
|
|
GS136128: listeriosis resistance 2 (Listr2, Published QTL Chr 13)
|
|
GS190714: GO:0016020 membrane
|
|
GS136967: Y-linked autoimmune acceleration QTL 1 (Yaa1, Published QTL Chr 13)
|
|
GS174658: HP:0001427 Mitochondrial inheritance
|
|
GS176171: HP:0001250 Seizures
|
|
GS195214: GO:0009987 cellular process
|
|
GS184452: GO:0044422 organelle part
|
|
GS180034: GO:0032502 developmental process
|
|
GS175673: HP:0100022 Abnormality of movement
|
|
GS171444: HP:0000602 Ophthalmoplegia
|
|
GS174335: HP:0001871 Abnormality of blood and blood-forming tissues
|
|
GS175714: HP:0011389 Functional abnormality of the inner ear
|
|
GS187023: GO:1901265 nucleoside phosphate binding
|
|
GS86906: Table S1: Additional data file 1 is a table listing the results of two-way ANOVA (FDR < 1%). Lists of probe sets and gene names altered by strain (3457). [DRG]
provisional
|
|
GS172097: HP:0000580 Pigmentary retinopathy
|
|
GS198263: GO:0005488 binding
|
|
GS203053: GO:0022900 electron transport chain
|
|
GS86932: Table S3: CORTEX 17K MICROARRAY [DRG]
|
|
GS175169: HP:0001317 Abnormality of the cerebellum
|
|
GS170996: HP:0007305 CNS demyelination
|
|
GS170971: HP:0000407 Sensorineural hearing impairment
|
|
GS136489: primordial germ cell tumor locus 1 (Pgct1, Published QTL Chr 13)
|
|
GS204180: GO:0070469 respiratory chain
|
|
GS209235: GO:0006793 phosphorus metabolic process
|
|
GS136681: skull morphology 20 (Skull20, Published QTL Chr 13)
|
|
GS207058: GO:0045283 fumarate reductase complex
|
|
GS172100: HP:0000587 Abnormality of the optic nerve
|
|
GS172362: HP:0004325 Decreased body weight
|
|
GS178159: GO:0006105 succinate metabolic process
|
|
GS180452: GO:0044237 cellular metabolic process
|
|
GS127939: Thalamus - Allen Mouse Brain Atlas
|
|
GS191477: GO:0045333 cellular respiration
|
|
GS172353: HP:0004329 Abnormality of the posterior segment of the eye
|
|
GS123977: 2,6-dichloro-4-nitrophenol interacting genes (MeSH:C015802) in CTD
|
|
GS136746: spermatogenesis defect 4 (Spmd4, Published QTL Chr 13)
|
|
GS181271: GO:0005740 mitochondrial envelope
|
|
GS125370: tolcapone interacting genes (MeSH:C066340) in CTD
|
|
GS33965: Cerebellum Gene expression correlates of Morphine distance (cm) travelled minutes 165-180 in Females BXD
|
|
GS136487: predicted fat percentage 3 (Pfat3, Published QTL Chr 13)
|
|
GS180164: GO:0008150 biological_process
|
|
GS175579: HP:0003200 Ragged-red muscle fibers
|
|
GS174812: HP:0001637 Abnormality of the myocardium
|
|
GS176333: HP:0007319 Morphological abnormality of the central nervous system
|
|
GS135451: bone length and organs 7 (Bod7, Published QTL Chr 13)
|
|
GS208854: GO:0045273 respiratory chain complex II
|
|
GS194434: GO:0051186 cofactor metabolic process
|
|
GS127930: Midbrain - Allen Mouse Brain Atlas
|
|
GS127933: Pons - Allen Mouse Brain Atlas
|
|
GS177721: GO:0051234 establishment of localization
|
|
GS210163: GO:0006082 organic acid metabolic process
|
|
GS190954: GO:0009056 catabolic process
|
|
GS171258: HP:0011138 Abnormality of skin adnexa
|
|
GS209455: GO:0003824 catalytic activity
|
|
GS184218: GO:0071704 organic substance metabolic process
|
|
GS135747: experimental allergic encephalomyelitis susceptibility 13 (Eae13, Published QTL Chr 13)
|
|
GS196559: GO:0019866 organelle inner membrane
|
|
GS177219: GO:0035383 thioester metabolic process
|
|
GS174646: HP:0000951 Abnormality of the skin
|
|
GS201949: GO:0044699 single-organism process
|
|
GS170917: HP:0100852 Abnormal fear/anxiety-related behavior
|
|
GS172666: HP:0011804 Abnormality of muscle physiology
|
|
GS175107: HP:0003808 Abnormal muscle tone
|
|
GS178461: GO:0009987 cellular process
|
|
GS136125: lipoprotein QTL 2 (Lipq2, Published QTL Chr 13)
|
|
GS193061: GO:0044444 cytoplasmic part
|
|
GS135348: Avp transcript abundance QTL 3 (Avptaq3, Published QTL Chr 13)
|
|
GS192624: GO:0043231 intracellular membrane-bounded organelle
|
|
GS186210: GO:0022900 electron transport chain
|
|
GS186743: GO:0043227 membrane-bounded organelle
|
|
GS172398: HP:0003287 Abnormality of mitochondrial metabolism
|
|
GS180799: GO:0006091 generation of precursor metabolites and energy
|
|
GS129182: spontaneous crescentic glomerulonephritis QTL 5 (Scgq5 Published QTL Chr 13)
|
|
GS86911: Table S1: Additional data file 1 is a table listing the results of two-way ANOVA (FDR < 1%). Lists of probe sets and gene names altered by morphine treatment (661). [DRG]
provisional
|
|
GS193268: GO:0005575 cellular_component
|
|
GS173786: HP:0003457 EMG abnormality
|
|
GS194039: GO:1901363 heterocyclic compound binding
|
|
GS127923: Cerebellum - Allen Mouse Brain Atlas
|
|
GS135682: Crh transcript abundance QTL 3 (Crhtaq3, Published QTL Chr 13)
|
|
GS194047: GO:0016627 oxidoreductase activity, acting on the CH-CH group of donors
|
|
GS135734: delta power in slow-wave sleep 1 (Dps1, Published QTL Chr 13)
|
|
GS205027: GO:0008177 succinate dehydrogenase (ubiquinone) activity
|
|
GS207581: GO:0007275 multicellular organismal development
|
|
GS204135: GO:0009060 aerobic respiration
|
|
GS171902: HP:0010987 Abnormality of cellular immune system
|
|
GS181962: GO:0016491 oxidoreductase activity
|
|
GS176817: HP:0011446 Abnormality of higher mental function
|
|
GS205002: GO:0048856 anatomical structure development
|
|
GS202188: GO:0044248 cellular catabolic process
|
|
GS174494: HP:0002564 Malformation of the heart and great vessels
|
|
GS86494: Table S1: Hippocampus 17 K microarray data. [DRG]
|
|
GS170783: HP:0010974 Abnormality of myeloid leukocytes
|
|
GS185724: GO:0043436 oxoacid metabolic process
|
|
GS201023: GO:0071704 organic substance metabolic process
|
|
GS84269: ethanol withdrawal (Published QTL, Chr 13)
|
|
GS173751: HP:0000998 Hypertrichosis
|
|
GS191106: GO:0044464 cell part
|
|
GS173290: HP:0011354 Generalized abnormality of skin
|
|
GS182174: GO:0031966 mitochondrial membrane
|
|
GS172031: HP:0000364 Hearing abnormality
|
|
GS136652: skeletal size (tail length) 6 (Skl6, Published QTL Chr 13)
|
|
GS174760: HP:0002376 Developmental regression
|
|
GS125842: Ascorbic Acid interacting genes (MeSH:D001205) in CTD
|
|
GS171453: HP:0003674 Onset
|
|
GS136271: modifier of obesity 2 (Mobe2, Published QTL Chr 13)
|
|
GS174187: HP:0001595 Abnormality of the hair
|
|
GS122634: Ketone Bodies interacting genes (MeSH:D007657) in CTD
|
|
GS171277: HP:0100547 Abnormality of the forebrain
|
|
GS192074: GO:1901575 organic substance catabolic process
|
|
GS173146: HP:0011282 Abnormality of the hindbrain
|
|
GS185585: GO:0044710 single-organism metabolic process
|
|
GS203056: GO:0022904 respiratory electron transport chain
|
|
GS172134: HP:0000639 Nystagmus
|
|
GS174397: HP:0003546 Exercise intolerance
|
|
GS171373: HP:0004897 Stress/infection-induced lactic acidosis
|
|
GS172853: HP:0004303 Abnormality of muscle fibers
|
|
GS172360: HP:0004323 Abnormality of body weight
|
|
GS135776: epistatic circling C C57L/J 2 (Eclc, Published QTL Chr 13)
|
|
GS175646: HP:0006980 Leukoencephalopathy, progressive
|
|
GS127926: Hippocampal region - Allen Mouse Brain Atlas
|
|
GS198059: GO:0005740 mitochondrial envelope
|
|
GS202415: GO:0044710 single-organism metabolic process
|
|
GS207903: GO:0044281 small molecule metabolic process
|
|
GS171488: HP:0002921 Abnormality of the cerebrospinal fluid
|
|
GS186159: GO:0016635 oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor
|
|
GS197593: GO:0006091 generation of precursor metabolites and energy
|
|
GS127932: Pallidum - Allen Mouse Brain Atlas
|
|
GS194133: GO:0005737 cytoplasm
|
|
GS189860: GO:0043167 ion binding
|
|
GS175525: HP:0000004 Onset and clinical course
|
|
GS194556: GO:0031975 envelope
|
|
GS188168: GO:0008177 succinate dehydrogenase (ubiquinone) activity
|
|
GS171855: HP:0000597 Ophthalmoparesis
|
|
GS125040: Thioacetamide interacting genes (MeSH:D013853) in CTD
|
|
GS191854: GO:0015980 energy derivation by oxidation of organic compounds
|
|
GS173079: HP:0000496 Abnormality of eye movement
|
|
GS136426: pulmonary adenoma susceptibility 10 (Pas10, Published QTL Chr 13)
|
|
GS177814: GO:0031975 envelope
|
|
GS172857: HP:0004305 Involuntary movements
|
|
GS184446: GO:0044429 mitochondrial part
|
|
GS135943: HDL cholesterol level 2 (Hdlcl2, Published QTL Chr 13)
|
|
GS171924: HP:0100578 Lipoatrophy
|
|
GS177031: HP:0011442 Abnormality of central motor function
|
|
GS135666: "cerebellum pattern fissures, declival 5" (Cpfd5, Published QTL Chr 13)
|
|
GS174836: HP:0001098 Abnormality of the fundus
|
|
GS199314: GO:0006732 coenzyme metabolic process
|
|
GS173246: HP:0001332 Dystonia
|
|
GS135981: wound healing/regeneration 8 (Heal8, Published QTL Chr 13)
|
|
GS185538: GO:0048037 cofactor binding
|
|
GS176170: HP:0001252 Muscular hypotonia
|
|
GS193991: GO:0048731 system development
|
|
GS187462: GO:0019752 carboxylic acid metabolic process
|
|
GS127929: Medulla - Allen Mouse Brain Atlas
|
|
GS177409: GO:0005739 mitochondrion
|
|
GS176803: HP:0001260 Dysarthria
|
|
GS184447: GO:0044424 intracellular part
|
|
GS207862: GO:0009056 catabolic process
|
|
GS201364: GO:0045257 succinate dehydrogenase complex (ubiquinone)
|
|
GS175191: HP:0002060 Abnormality of the cerebrum
|
|
GS195036: GO:0031090 organelle membrane
|
|
GS171496: HP:0008314 Decreased activity of mitochondrial complex II
|
|
GS210212: GO:0005575 cellular_component
|
|
GS174081: HP:0004322 Short stature
|
|
GS176202: HP:0000479 Abnormality of the retina
|
|
GS185928: GO:0050660 flavin adenine dinucleotide binding
|
|
GS197357: GO:0005746 mitochondrial respiratory chain
|
|
GS135573: cystic fibrosis body weight 5 (Cfbw5, Published QTL Chr 13)
|
|
GS195139: GO:0055114 oxidation-reduction process
|
|
GS179580: GO:0036094 small molecule binding
|
|
GS176801: HP:0001263 Global developmental delay
|
|
GS176759: HP:0000982 Palmoplantar keratoderma
|
|
GS174500: HP:0000707 Abnormality of the nervous system
|
|
GS171998: HP:0001939 Abnormality of metabolism/homeostasis
|
|
GS176834: HP:0002793 Abnormal respiratory patterns
|
|
GS182834: GO:0005623 cell
|
|
GS176167: HP:0001257 Spasticity
|
|
GS174914: HP:0003011 Abnormality of the musculature
|
|
GS194433: GO:0051187 cofactor catabolic process
|
|
GS171217: HP:0003487 Babinski sign
|
|
GS174814: HP:0001639 Hypertrophic cardiomyopathy
|
|
GS176038: HP:0002795 Functional respiratory abnormality
|
|
GS182762: GO:0043648 dicarboxylic acid metabolic process
|
|
GS196943: GO:0008152 metabolic process
|
|
GS173560: HP:0008316 Abnormal mitochondria in muscle tissue
|
|
GS199634: GO:0005623 cell
|
|
GS198970: GO:0031967 organelle envelope
|
|
GS176973: HP:0001072 Thickened skin
|
|
GS136028: hyperinsulinemia (Hypism, Published QTL Chr 13)
|